{"id":"https://openalex.org/W2000574536","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.e18560","title":"Phase I dose-escalation (DE) trial of high-dose melphalan (M) with palifermin (P) for cytoprotection followed by autologous stem cell transplantation (ASCT) for myeloma (MM) patients with abnormal renal function (AbRF).","display_name":"Phase I dose-escalation (DE) trial of high-dose melphalan (M) with palifermin (P) for cytoprotection followed by autologous stem cell transplantation (ASCT) for myeloma (MM) patients with abnormal renal function (AbRF).","publication_year":2010,"publication_date":"2010-05-20","ids":{"openalex":"https://openalex.org/W2000574536","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.e18560","mag":"2000574536"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2010.28.15_suppl.e18560","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.e18560","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.e18560","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5048231568","display_name":"N. Tageja","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"N. Tageja","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086538924","display_name":"Zaid S Al-Kadhimi","orcid":"https://orcid.org/0000-0002-6820-8786","observed_orcids":["https://orcid.org/0000-0002-6820-8786"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Z. S. Al-Kadhimi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028497782","display_name":"Simon M. Cronin","orcid":"https://orcid.org/0000-0002-2652-4676","observed_orcids":["https://orcid.org/0000-0002-2652-4676"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Cronin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016774003","display_name":"Judith Abrams","orcid":"https://orcid.org/0000-0001-9171-6458","observed_orcids":["https://orcid.org/0000-0001-9171-6458"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Abrams","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5037082058","display_name":"Marie Ventimiglia","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Ventimiglia","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046786751","display_name":"Lawrence G. Lum","orcid":"https://orcid.org/0000-0001-7561-6035","observed_orcids":["https://orcid.org/0000-0001-7561-6035"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. G. Lum","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091089490","display_name":"Lois Jeanne Ayash","orcid":"https://orcid.org/0000-0003-0355-1775","observed_orcids":["https://orcid.org/0000-0003-0355-1775"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. J. Ayash","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069623488","display_name":"V. Ratanatharathorn","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V. Ratanatharathorn","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109542492","display_name":"Joseph P. Uberti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. P. Uberti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5055027283","display_name":"Muneer Hyder Abidi","orcid":"https://orcid.org/0000-0002-9936-6031","observed_orcids":["https://orcid.org/0000-0002-9936-6031"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. H. Abidi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"28","issue":"15_suppl","first_page":"e18560","last_page":"e18560"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11221","display_name":"Bone health and treatments","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/melphalan","display_name":"melphalan","score":0.9279999732971191},{"id":"https://openalex.org/keywords/palifermin","display_name":"palifermin","score":0.9940000176429749},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9269999861717224},{"id":"https://openalex.org/keywords/autologous-stem-cell-transplantation","display_name":"autologous stem cell transplantation","score":0.9490000009536743},{"id":"https://openalex.org/keywords/conditioning-regimen","display_name":"conditioning regimen","score":0.6119999885559082},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.7559999823570251},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.9190000295639038},{"id":"https://openalex.org/keywords/oral-mucositis","display_name":"oral mucositis","score":0.9139999747276306},{"id":"https://openalex.org/keywords/cytoprotection","display_name":"cytoprotection","score":0.8859999775886536},{"id":"https://openalex.org/keywords/high-dose-chemotherapy","display_name":"high-dose chemotherapy","score":0.6890000104904175},{"id":"https://openalex.org/keywords/renal-dysfunction","display_name":"renal dysfunction","score":0.3880000114440918},{"id":"https://openalex.org/keywords/hematopoietic-stem-cell-transplantation","display_name":"hematopoietic stem cell transplantation","score":0.5989999771118164},{"id":"https://openalex.org/keywords/cardiotoxicity","display_name":"cardiotoxicity","score":0.4569999873638153},{"id":"https://openalex.org/keywords/diarrhea","display_name":"diarrhea","score":0.7590000033378601},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.5440000295639038},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.5109999775886536},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.4300000071525574}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9045957326889038},{"id":"https://openalex.org/C2778496288","wikidata":"https://www.wikidata.org/wiki/Q6931269","display_name":"Mucositis","level":3,"score":0.7546509504318237},{"id":"https://openalex.org/C2778684742","wikidata":"https://www.wikidata.org/wiki/Q2298283","display_name":"Melphalan","level":3,"score":0.5051348805427551},{"id":"https://openalex.org/C126894567","wikidata":"https://www.wikidata.org/wiki/Q105650","display_name":"Urology","level":1,"score":0.48629459738731384},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4803260862827301},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.47909122705459595},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.44652628898620605},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.41412603855133057},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.38105514645576477},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.3428132236003876}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2010.28.15_suppl.e18560","doi":"https://doi.org/10.1200/jco.2010.28.15_suppl.e18560","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2010.28.15_suppl.e18560","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4242007866","https://openalex.org/W4253937502","https://openalex.org/W2544608079","https://openalex.org/W2148470027","https://openalex.org/W1969056907","https://openalex.org/W2465566945","https://openalex.org/W3002142437","https://openalex.org/W2100301113","https://openalex.org/W4310162516","https://openalex.org/W4409954983"],"abstract_inverted_index":{"e18560":[0],"Background:":[1],"Melphalan":[2],"(M)":[3],"is":[4,34,338],"the":[5,35,71,84,126,144,187,257,277,356,384],"most":[6],"effective":[7],"conditioning":[8,37],"agent":[9,98],"for":[10,87,178,390],"MM":[11,391],"patients":[12,392],"(pts)":[13],"undergoing":[14],"ASCT.":[15,93,179],"M":[16,31,48,65,81,129,196,234,270,342,385],"pharmacokinetics":[17],"(PK)":[18],"are":[19],"not":[20],"adversely":[21],"affected":[22],"by":[23,245],"AbRF.":[24],"Despite":[25],"its":[26],"steep,":[27],"log-linear":[28],"dose":[29,82,188,259,274,386],"effect,":[30],"140":[32,197],"mg/m2":[33,198,230,352,388],"standard":[36],"regimen":[38],"in":[39,67,70,102,109,130,345],"pts":[40,110,131,155,183,253,316,367],"with":[41,75,78,140,200,272,393],"AbRF":[42,135],"because":[43],"of":[44,47,64,107,128,148,251,301,362,378],"pronounced":[45],"toxicity":[46,288,296,310],">":[49],"200":[50,351,387],"mg/m2.":[51,236],"In":[52,114],"a":[53,96],"retrospective":[54],"review,":[55],"(Grazziutti":[56],"et":[57],"al)":[58],"concluded":[59],"that":[60,273],"BSA":[61],"based":[62,133],"dosing":[63],"results":[66],"wide":[68],"variations":[69],"mg/kg":[72,80],"dose.":[73],"Pts":[74],"AbRF,":[76],"treated":[77],"high":[79],"have":[83,156],"greatest":[85],"risk":[86],"severe":[88],"oral":[89,309],"mucositis":[90],"(OM)":[91],"following":[92],"P":[94,141,201,373],"as":[95,205,276],"cytoprotective":[97],"has":[99],"demonstrated":[100],"efficacy":[101],"reducing":[103],"intensity":[104],"and":[105,146,176,217,283,323,349],"duration":[106,145],"OM":[108,175,302],"receiving":[111],"intensive":[112],"chemo-radiotherapy.":[113],"an":[115,248],"effort":[116],"to":[117,124,142,233,263,307,314,332,348,368],"DE":[118,180,225,261,377],"M,":[119,379],"we":[120,358],"designed":[121],"this":[122,370],"study":[123],"determine":[125],"MTD":[127],"stratified":[132],"on":[134,186,208,221,355],"(CrCl":[136],"<60)":[137],"when":[138],"used":[139,389],"decrease":[143],"severity":[147],"OM.":[149],"Methods:":[150],"Since":[151],"July":[152],"2007,":[153],"14":[154],"been":[157],"enrolled.":[158],"Eligibility":[159],"criteria":[160],"included":[161],"age":[162],"18-74":[163],"years,":[164],"stage":[165],"2/3,":[166],"ECOG":[167],"PS":[168],"\u2264":[169],"2,":[170],"no":[171,173,238],"dialysis,":[172],"active":[174],"suitable":[177],"proceeded":[181],"(3":[182],"cohorts)":[184],"depending":[185],"limiting":[189],"toxicities":[190],"(DLT).":[191],"Level":[192],"1":[193],"began":[194],"at":[195,228,256,269],"(D-2)":[199],"60":[202],"mcg/kg/d,":[203],"given":[204,344],"I.V.":[206],"bolus":[207],"Day":[209,214,222,330],"-5,-4,":[210],"-":[211],"3":[212,252,286],"&":[213],"+1,":[215],"+2":[216],"+3":[218],"(PBSCs":[219],"infused":[220],"0).":[223],"Subsequent":[224],"were":[226,243,254,262],"done":[227],"20":[229],"increments":[231],"up":[232,347],"220":[235],"If":[237],"symptomatic":[239],"grade":[240,285,292,300],"\u22653":[241],"DLTs":[242,267],"noted":[244],"day":[246],"+30,":[247],"additional":[249],"cohort":[250],"entered":[255],"next":[258],"level.":[260],"stop":[264],"if":[265],"\u22652":[266],"occurred":[268],"dose;":[271],"declared":[275],"MTD.":[278],"Grade":[279],"3/":[280,293],"4":[281,294,363],"diarrhea":[282],"\u2265":[284],"cardiac":[287],"was":[289,297,303,327,343],"considered":[290],"DLT;":[291],"hematological":[295],"acceptable.":[298],"The":[299],"assessed":[304],"daily":[305],"according":[306],"WHO":[308],"scale":[311],"(grade":[312],"0":[313],"4).The":[315],"reported":[317],"questionnaire":[318],"evaluating":[319],"overall":[320],"health,":[321],"mouth":[322],"throat":[324],"soreness":[325],"(MTS)":[326],"administered":[328],"from":[329],"-5":[331],"+":[333],"28.":[334],"Results:":[335],"This":[336],"trial":[337],"still":[339],"recruiting":[340],"pts.":[341],"doses":[346],"including":[350],"(n=2).":[353],"Based":[354],"DLT":[357],"would":[359],"need":[360],"minimum":[361],"or":[364,382,400,404],"maximum":[365],"7":[366],"complete":[369],"study.":[371],"Conclusions:":[372],"may":[374],"permit":[375],"safe":[376],"thus":[380],"reaching":[381],"exceeding":[383],"normal":[394],"renal":[395],"function.":[396],"Author":[397],"Disclosure":[398],"Employment":[399],"Leadership":[401],"Position":[402],"Consultant":[403],"Advisory":[405],"Role":[406],"Stock":[407],"Ownership":[408],"Honoraria":[409],"Research":[410],"Funding":[411],"Expert":[412],"Testimony":[413],"Other":[414],"Remuneration":[415],"Biovitrium":[416]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2016-06-24T00:00:00"}